Overview

Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Investigate safety/tolerability after a single dose intranasal administration of AZD8848 comparator placebo to healthy male volunteers and seasonal allergic rhinitis male patients out of season
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca